Mahmoud, D.E.; Hosseini, S.H.; Rathore, H.A.; Alkilany, A.M.; Heise, A.; Elhissi, A.
Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases. Pharmaceutics 2025, 17, 893.
https://doi.org/10.3390/pharmaceutics17070893
AMA Style
Mahmoud DE, Hosseini SH, Rathore HA, Alkilany AM, Heise A, Elhissi A.
Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases. Pharmaceutics. 2025; 17(7):893.
https://doi.org/10.3390/pharmaceutics17070893
Chicago/Turabian Style
Mahmoud, Doaa Elsayed, Seyedeh Hanieh Hosseini, Hassaan Anwer Rathore, Alaaldin M. Alkilany, Andreas Heise, and Abdelbary Elhissi.
2025. "Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases" Pharmaceutics 17, no. 7: 893.
https://doi.org/10.3390/pharmaceutics17070893
APA Style
Mahmoud, D. E., Hosseini, S. H., Rathore, H. A., Alkilany, A. M., Heise, A., & Elhissi, A.
(2025). Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases. Pharmaceutics, 17(7), 893.
https://doi.org/10.3390/pharmaceutics17070893